AI tools are here to supercharge the efforts of patent attorneys during prosecution, and this is more important now than ever in the life sciences industry. This session will explore the deployment of AI tools in navigating complex technical disclosures in biotech and pharma, and the potential benefits of freeing up attorneys time to focus on the strategic aspects away from patent drafting where they can really add value.
In an industry where the margin for error is miniscule, panelists will discuss the rapidly shifting legal landscape and common reservations of those reluctant to embrace AI. Discussion will consider data integrity, disclosure, and how to apply effective guardrails to embrace innovation while minimizing risk to secure a competitive advantage.